# COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.

> **NCT00377481** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 48 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** darbepoetin alfa
- **DRUG:** epoetin beta [NeoRecormon]

## Key facts

- **NCT ID:** NCT00377481
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00377481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00377481, "COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00377481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*